June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
The current clinical profile of patients eligible for glaucoma surgery and related type of intervention
Author Affiliations & Notes
  • Sara Giammaria
    IRCSS Fondazione G B Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS, Roma, Lazio, Italy
  • Michele Figus
    Department of Surgical, Medical, Molecular Pathology and of Critical Area, Universita degli Studi di Pisa, Pisa, Toscana, Italy
  • Gianluca Manni
    Universita degli Studi di Roma Tor Vergata, Roma, Lazio, Italy
  • Matteo Sacchi
    Eye Clinic, Ospedale Generale San Giuseppe, Milano, Lombardia, Italy
    IRCCS MultiMedica, Milano, Lombardia, Italy
  • Gaia Li Calzi
    Eye Clinic, Ospedale Generale San Giuseppe, Milano, Lombardia, Italy
    IRCCS MultiMedica, Milano, Lombardia, Italy
  • Alessandro Palma
    Department of Surgical, Medical, Molecular Pathology and of Critical Area, Universita degli Studi di Pisa, Pisa, Toscana, Italy
  • Maria Novella Maglionico
    Department of Surgical, Medical, Molecular Pathology and of Critical Area, Universita degli Studi di Pisa, Pisa, Toscana, Italy
  • Francesco Oddone
    IRCSS Fondazione G B Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS, Roma, Lazio, Italy
  • Footnotes
    Commercial Relationships   Sara Giammaria None; Michele Figus None; Gianluca Manni None; Matteo Sacchi None; Gaia Li Calzi None; Alessandro Palma None; Maria Novella Maglionico None; Francesco Oddone Abbvie Allergan, Code C (Consultant/Contractor), Santen, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 4279. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sara Giammaria, Michele Figus, Gianluca Manni, Matteo Sacchi, Gaia Li Calzi, Alessandro Palma, Maria Novella Maglionico, Francesco Oddone; The current clinical profile of patients eligible for glaucoma surgery and related type of intervention. Invest. Ophthalmol. Vis. Sci. 2023;64(8):4279.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Despite timely surgical intervention is crucial for visual outcome and overall success, a large proportion of glaucoma patients are believed to be referred for surgery when damage is already advanced and ocular surface tissues compromised.
The recent introduction of new filtering devices with potentially improved predictability and safety profile may help reshaping the indications for glaucoma surgery.
This retrospective, multicenter, observational study aims to explore the characteristics of patients referred for glaucoma surgery and whether these features influence to the chioce of the type of intervention.

Methods : Records of patients who underwent filtering surgery with [PreserFlo (PF) and XEN] or without devices (trabeculectomy) in 4 Italian tertiary glaucoma centers between 10-2021 and 10-2022 have been retrospectively reviewed. Patients were profiled by analyzing:

- demographics;
- preoperative intraocular pressure (IOP);
- visual field damage [mean deviation (MD) and type of defect];
- status of the lens;
- number of ocular hypotensive agents (OHAs).

Multinomial logistic regression models have been applied to test the relationship between these variables and the type of surgery.

Results : A total of 432 eyes have been included. Clinical characteristics of patients and comparisons between surgery groups are listed in Table I.
Two hundred and six eyes (47.7%) showed an MD worse than -12 dB and 126 (29.1%) had an end stage or tunnel visual field at the time of surgery.
Patients were treated with a mean of 2.6±0.9 OHAs and 15.7% with >3 OHAs (of whom 47% with additional oral acetazolamide). When compared to trabeculectomy, both PF and XEN surgeries were associated with better MD [OR (95%CI) 1.03 (1.0 – 1.06), p<0.05 and 1.07 (1.03 – 1.10), p<0.01 respectively] and higher number of OHAs [OR 1.64 (1.20 – 2.25), p<0.01 and 1.46 (1.20 – 2.25), p<0.05 respectively]. XEN surgery was also associated with higher IOP [OR (95%CI): 1.05 (1.01 – 1.09), p<0.01]. Undergoing PF was associated with younger age [OR (95%CI): (0.95 – 0.99), p<0.01] whereas combined PF and phacoemulsification with older age [OR (95%CI): 1.03 (1.01 – 1.05), p<0.05].

Conclusions : Glaucoma surgery is still proposed as a late option in a large proportion of patients. The use of filtering devices is associated with earlier damage and more intense preoperative therapy.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Table I. Clinical characteristics of glaucoma patients.

Table I. Clinical characteristics of glaucoma patients.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×